Profil
Peter D.
O'Hanley was Senior Vice President of Clinical Development and Regulatory Affairs for AVI BioPharma, Inc. from March 2004 to January 9, 2009.
From 2002 to 2003, he was Vice President of Clinical Development for Maxygen, Inc. and Chief Scientific Officer of Preventis, Inc. from 2000 to 2003.
Dr. O'Hanley was Vice President and Chief Scientific Officer of the Anti-Infective Therapeutic & Immunology Therapeutic Groups for Quintiles, Inc. from 1998 to 2000.
He was a Visiting Clinical Scientist of Shaman Pharmaceuticals from 1996 to 1997 and an Associate Professor at the Stanford University School of Medicine from 1985 to 1998.
Dr. O'Hanley received a BA degree in Zoology from Pomona College, a PhD in Anatomy and an MD from the Medical University of South Carolina and an MPH in Epidemiology from the University of California at Berkeley.
Postes actifs de Peter D. O'Hanley
| Sociétés | Poste | Début |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1985 |
Anciens postes connus de Peter D. O'Hanley
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 09/01/2009 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Preventis, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Corporate Officer/Principal | 01/01/2000 |
Formation de Peter D. O'Hanley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Pomona College
Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Preventis, Inc. |
















